Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Offices

Mainz, DEU
Freiligrathstraße 12
Mainz, 55131, DEU

People

Funding

TOTAL $5.7M
FUNDING TOTAL $5.7M
Series C, 5/2010
VRP Rhineland Palatinate Fund
KfW Bankengruppe
WFT Ventures
High-Tech Gruenderfonds
$5.7M

Tags

Galantos Pharma

Galantos Pharma GmbH focuses on the development of drugs for the treatment of Alzheimer’s and other neurodegenerative diseases. It develops a drug for the treatment of mild-to-moderate Alzheimer’s dementia. The company develops a technology platform that is suitable for screening and preclinical validation of drug candidates that are acting on cholinergic and other neuro-receptors and on various brain enzymes. The company was founded in 2005 and is based in Mainz, Germany.

Recent Milestones

Videos

Screenshots

Sources

  1. Galantos Pharma, GmbH: Series C $5.7M (onbiovc.com) [edit]
Edit This Page
Last Edited 5/10/10

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy